4th Annual Rockin' Purple for Lupus Ride was a huge success!
Join the webinar on Wed., August 26
Results from a study of epratuzumab were recently released. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease.
View current and past issues of our Chapter newsletter.
An Invitation for Participation in our Strategic Planning Process